The effectiveness of Smartphone application-based education “Teman Diabetes” on clinical outcomes of Type-2 Diabetes mellitus patients

Author:

Hasanah Nidaul1,Ikawati Zullies2,Akbar Zainal Zainol3

Affiliation:

1. Master Program of Clinical Pharmacy, Faculty of Pharmacy, Gadjah Mada University, Indonesia.

2. Faculty of Pharmacy, Gadjah Mada University, Indonesia.

3. Faculty of Pharmacy, University of Cyberjaya, Selangor, Malaysia.

Abstract

Introduction: Smartphone-based education has been proven to indirectly improve clinical outcomes of type-2 diabetes mellitus patients via practical disease management. “Teman Diabetes” is a new smartphone application that helps diabetics better manage their diabetes, and allows collaboration between diabetics, their inner circle, and medical professionals. However, there is still limited evidence about the effectiveness of “Teman Diabetes” on clinical outcomes of diabetic patients, especially type-2 diabetes mellitus. The objective of this research is to determine the positive effect of smartphone application-based education “Teman Diabetes” on the clinical outcomes of type-2 diabetes mellitus patients. The clinical outcomes measured were HbA1c and fasting plasma glucose levels. Method: Using a quasi-experimental design, a total of 83 participants were selected by consecutive sampling. Patients in the intervention group (n = 44) received "Teman Diabetes" when they assigned the informed consent form. Furthermore, they received a WhatsApp message containing a different link from the "Artikel" feature on the Teman Diabetes every week from the research team, from the second week to twelfth week. The control group (n = 39) only received standard therapy without any additional interventions. Patients in both groups were followed before and after 3 months (HbA1c and fasting plasma glucose levels). The statistical test used in this study is Mann-Whitney test for hypotheses and comparison of mean changes between groups; Wilcoxon test for comparison of mean changes between treatments; and analysis of covariance (ANCOVA) test for the effect of confounding variables. Results: After 3 months, the mean HbA1c reduction was greater in the intervention group by -0.7 ± 0.9% (P<0.001) than in the control group by -0.1 ± 1.1% (P=0.17). Also, the mean fasting plasma glucose reduction was greater in the intervention group by -25.0 ± 71.4mg/dl (P=.02) instead of in the control group by 7.6 ± 72.4mg/dl (P=0.78). It is concluded that smartphone application-based education “Teman Diabetes” give a significant positive effect on clinical outcomes among type-2 diabetes mellitus patients. The main features that contributed to the clinical outcome of this study were "Artikel", "Forum", and "Edukasi" feature.

Publisher

A and V Publications

Subject

Pharmacology (medical),Pharmacology, Toxicology and Pharmaceutics (miscellaneous)

Reference28 articles.

1. WHO. Diabetes. Available from: URL: https://www.who.int/health-topics/diabetes#tab=tab_1.

2. WHO, Global diffusion of eHealth: Making universal health coverage achievable. Report of the third global survey on eHealth. 2016. Available from: URL. https://www.who.int/goe/publications/global_diffusion/en/

3. ADA. The Role of Telehealth in an Evolving Health Care Environment : Workshop Summary. 2012 [cited 2020 July 1st]; Available from: URL: https://www.ncbi.nlm.nih.gov/books/NBK207145/#!po=16.6667.

4. Glassroth, H., American Telemedicine Association Advocacy Initiatives Result in New Medicare Coverage for Chronic Condition Monitoring. American Telemedicine Association, 2017. Available from: URL: https://www.americantelemed.org/press-releases/american-telemedicine-association-advocacy-initiatives-result-in-new-medicare-coverage-for-chronic-condition-monitoring/

5. Guesehat.com. Mudahnya mengelola Diabetes Melalui Aplikasi Teman Diabetes. 2020 [cited 2020 July 1st]; Available from: https://www.guesehat.com/mudahnya-mengelola-diabetes-melalui-aplikasi-teman-diabetes.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3